Several papers have been generated as the result of research facilitated by Rambam's biobank.
- Yang Y, Ishak Gabra MB, Hanse EA, Lowman XH, Tran TQ, Li H, Milman N, Liu J, Reid MA, Locasale JW, Gil Z, Kong M. MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1. Nat Commun. 2019 Feb 18;10(1):809. doi: https://doi.org/10.1038/s41467-019-08759-0
- Goshen-Lago T, Szwarcwort-Cohen M, Benguigui M, et al. The Potential Role of Immune Alteration in the Cancer-COVID19 Equation-A Prospective Longitudinal Study. Cancers (Basel). 2020;12(9):E2421. Published 2020 Aug 26. doi: https://doi.org/10.3390/cancers12092421
- Ali Khateb, Anagha Deshpande, Yongmei Feng, Joo Sang Lee, Ikrame Lazar, Bertrand Fabre, Yan Li, Darren Finlay, Yu Fujita, Tongwu Zhang, Jun Yin, Ian Pass, Ido Livneh, Carol Burian, James R Mason, Ronit Almog, Nurit Horesh, Yishai Ofran, Kevin Brown, Kristiina Vuori, Michael Jackson, Eytan Ruppin, Aniruddha J Deshpande, Ze'ev A Ronai. RNF5 Regulation of RBBP4 Defines Acute Myeloid Leukemia Growth and Susceptibility to Histone Deacetylase Inhibitors. bioRxiv 2020.10.25.349241; doi: https://doi.org/10.1101/2020.10.25.349241
- Erez Hasnis, Hyungsoo Kim, Sachin Verma, Yongmei Feng, Ronit Almog, Sivan Matsliah, Vera Vavinskaya, Ron Apelbaum, Offir Ben-Ishay, David Tuveson, Rosalie Sears, Ze’ev A. Ronai. Regulation of HDAC2-PDX1 by RNF125 defines pancreatic cancer development. bioRxiv 2020.01.06.896555; doi: https://doi.org/10.1101/2020.01.06.896555
- Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368(6494):973-980. doi: https://doi.org/10.1126/science.aay9189
- Mandel I, Haves Ziv D, Goldshtein I, et alBND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regressionJournal for ImmunoTherapy of Cancer 2022;10:e004859. doi: 10.1136/jitc-2022-004859